Stem cell therapy in stroke

Abstract

Stroke is the leading cause of neurological disability in adults worldwide and involves the significant impairment of sensory-motor function caused by cerebral ischemia and subsequent neuronal death. Owing to a lack of medical or surgical treatments to improve neurological function and neurogenesis, chronic stroke places a huge burden on patients, their families, and society. Over the past twenty years, increasing evidence from translational and clinical research has demonstrated the potential effectiveness of hematopoietic growth factors and stem cell administration or transplantation in the treatment of stroke. In particular, these studies have included granulocyte colony-stimulating factor, mesenchymal stem cells, autologous CD34⁺ peripheral blood stem cells, umbilical cord blood stem cells, and autologous adipose-derived mesenchymal stem cells. It is therefore important to consider the safety of these putative therapies whilst achieving the maximum benefit for patients with chronic stroke in terms of the route of administration and stem cell numbers. In this review, we discuss current evidence and the progress that has been made in our hospital, which paves the way for the next neurogenesis therapy for chronic stroke.

Keywords

Stem cells / stroke / therapy / neural stem cells / mesenchymal stem cells

References

[1] Feigin VL,Bennett DA,Parag V.Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review..Lancet Neurol2009;8:355-69

[2] Huang ZS,Lee TK.Stroke prevalence in Taiwan. Findings from the 1994 National Health Interview Survey..Stroke1997;28:1579-84

[3] Feigin VL,Bennett DA.Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century..Lancet Neurol2003;2:43-53

[4] Jørgensen HS,Raaschou HO,Støier M.Outcome and time course of recovery in stroke. Part II: Time course of recovery. The copenhagen stroke study..Arch Phys Med Rehabil1995;76:406-12

[5] Winstein CJ,Arena R.Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association..Stroke2016;47:e98-e169

[6] Powers WJ,Ackerson T.2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association..Stroke2018;49:e46-e110

[7] Chugh C.Acute ischemic stroke: management approach..Indian J Crit Care Med2019;23:S140-6 PMCID:PMC6707502

[8] Yeo SH,Mao J.Effects of central nervous system drugs on recovery after stroke: a systematic review and meta-analysis of randomized controlled trials..Clin Drug Investig2017;37:901-28

[9] Shyu WC,Lee CC,Li H.Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial..CMAJ2006;174:927-33 PMCID:PMC1405861

[10] Chang YH,Harn HJ,Ding DC.Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy..Cell Transplant2018;27:349-63 PMCID:PMC6038041

[11] Ding DC,Lin SZ.Current concepts in adult stem cell therapy for stroke..Curr Med Chem2006;13:3565-74

[12] Ding DC,Shyu WC.Neural stem cells and stroke..Cell Transplant2013;22:619-30

[13] Ehrhart J,Garbuzova-Davis S.Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseases..J Cell Mol Med2018;22:6157-66 PMCID:PMC6237605

[14] Zheng H,Chhatbar PY.Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research..Cell Transplant2018;27:1723-30 PMCID:PMC6300779

[15] Vendrame M,Newcomb J.Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume..Stroke2004;35:2390-5

[16] Sanberg PR.A Hallmark Clinical Study of Cord Blood Therapy in Adults with Ischemic Stroke..Cell Transplant2019;28:1329-32 PMCID:PMC6767876

[17] Vendrame M,Pennypacker KR.Cord blood rescues stroke-induced changes in splenocyte phenotype and function..Exp Neurol2006;199:191-200

[18] Liu SP,Wang HJ.Nonsenescent Hsp27-upregulated MSCs implantation promotes neuroplasticity in stroke model..Cell Transplant2010;19:1261-79

[19] Ding DC,Chiang MF.Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model..Neurobiol Dis2007;27:339-53

[20] Fu YS,Cheng YC.Transformation of human umbilical mesenchymal cells into neurons in vitro..J Biomed Sci2004;11:652-60

[21] Hosseini SM,Nakhlparvar N,Talaei-Khozani T.Differentiation of Wharton’s jelly mesenchymal stem cells into neurons in alginate scaffold..Neural Regen Res2015;10:1312-6 PMCID:PMC4590246

[22] Fujita J,Kawada H.Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair..Stem Cells2007;25:2750-9

[23] Solaroglu I,Tsubokawa T,Zhang JH.Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation..Neurol Res2009;31:167-72

[24] Kong T,Park H.Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation..J Neurosurg2009;111:155-63

[25] Shyu WC,Yang HI.Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells..Circulation2004;110:1847-54

[26] Demetri GD.Granulocyte colony-stimulating factor and its receptor..Blood1991;78:2791-808

[27] Shyu WC,Chiang MF,Li H.Intracerebral peripheral blood stem cell (CD34⁺) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats..J Neurosci2006;26:3444-53 PMCID:PMC6673856

[28] Chen DC,Fan JR.Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study..Cell Transplant2014;23:1599-612

[29] Song M,Gu X,Yu SP.Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice..Cell Transplant2013;22:2001-15

[30] Brenneman M,Harting M.Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats..J Cereb Blood Flow Metab2010;30:140-9 PMCID:PMC2893568

[31] Kamiya N,Igarashi H.Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats..Life Sci2008;83:433-7

[32] Iihoshi S,Houkin K,Kocsis JD.A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats..Brain Res2004;1007:1-9

[33] Nowakowski A,Janowski M.Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine..Stem Cells Dev2015;24:2219-42

[34] Hwang BW,Park KM.Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels..J Control Release2015;220:119-29

[35] Kurozumi K,Tamiya T.BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model..Mol Ther2004;9:189-97

[36] Smith EJ,Gorenkova N.Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke..Stem Cells2012;30:785-96

[37] Zhang G,Reuss JL.Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic Stroke..Stem Cells Transl Med2019;8:999-1007 PMCID:PMC6766600

[38] Zhang G,Zhang H.First Human Trial of Stem Cell Transplantation in Complex Arrays for Stroke Patients Using the Intracerebral Microinjection Instrument..Oper Neurosurg (Hagerstown)2020;18:503-10

[39] Wu W,Hu C,Yu Z.Transplantation of neural stem cells expressing hypoxia-inducible factor-1alpha (HIF-1alpha) improves behavioral recovery in a rat stroke model..J Clin Neurosci2010;17:92-5

[40] Stroemer P,Hope A,Pollock K.The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion..Neurorehabil Neural Repair2009;23:895-909

[41] Strecker JK,Hoppen M.Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune Response After Stroke in Mice..Stroke2016;47:852-62

[42] England TJ,Alasheev AM.Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis..Sci Rep2016;6:36567 PMCID:PMC5109224

[43] Wagner DC,Schulz I.Allometric dose retranslation unveiled substantial immunological side effects of granulocyte colony-stimulating factor after stroke..Stroke2014;45:623-6

[44] Singh M,Bhasin A,Mohanty S.Application of Stem Cells in Stroke: A Multifactorial Approach..Front Neurosci2020;14:473 PMCID:PMC7296176

[45] Ding DC,Lin SZ.Mesenchymal stem cells..Cell Transplant2011;20:5-14

[46] Scruggs BA,Zhang X.Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model..Stem Cells Transl Med2013;2:797-807 PMCID:PMC3785264

[47] Gutiérrez-Fernández M,Otero-Ortega L,Fuentes B.Adipose tissue-derived stem cells in stroke treatment: from bench to bedside..Discov Med2013;16:37-43

[48] Hess DC,Furlan AJ,Switzer JA.A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke..Int J Stroke2014;9:381-6

[49] Vahidy FS,Zhu H,Bambhroliya AB.Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke..Stroke2016;47:1632-9 PMCID:PMC4879076

[50] Chan TM,Lin HP.The use of ADSCs as a treatment for chronic stroke..Cell Transplant2014;23:541-7

[51] Prasad K,Garg A.Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial..Stroke2014;45:3618-24

[52] Watanabe M.Intra-arterial delivery of mesenchymal stem cells..Brain Circ2016;2:114-7 PMCID:PMC6126270

[53] Sung PH,Lin WC.Intra-carotid arterial transfusion of autologous circulatory derived CD34⁺ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability..Am J Transl Res2018;10:2975-89 PMCID:PMC6176223

[54] Wang Y,Li Y.Roles of chemokine CXCL12 and its receptors in ischemic stroke..Curr Drug Targets2012;13:166-72

[55] Sarugaser R,Keating A,Davies JE.Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy..PLoS One2009;4:e6498 PMCID:PMC2714967

[56] Hernández R,Perales-Adán J,Melguizo C.Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders..Biomol Ther (Seoul)2020;28:34-44 PMCID:PMC6939692